Clinical trial
Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB…
NCT00003042 · City of Hope Medical Center, Other · Active, not recruiting
Key facts
| NCT number | NCT00003042 |
|---|---|
| Title | Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer |
| Official title | Dose-Intense Chemotherapy and Stem Cell Rescue in the Treatment of Inflammatory Breast Carcinoma |
| Lead sponsor | City of Hope Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, cisplatin, cyclophosphamide, doxorubicin hydrochloride, melphalan, mesna, paclitaxel, tamoxifen citrate, bone marrow ablation with stem cell support, conventional surgery and 1 more |
| Enrollment | 41 |
| Start date | May 30, 1997 |
| Primary completion | Feb 9, 2010 |
| Completion | Dec 29, 2025 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 3, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: